Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00293761
NCT00293761CompletedPhase 3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research0 sites109 target enrollmentStarted: January 2006Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
109
Primary Endpoint
Mean IOP
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.
  • •Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • •Under age
  • •Other protocol-defined exclusion criteria may apply.

Arms & Interventions

Travatan, Investigational

Experimental

Intervention: Travoprost, Investigational (Drug)

Travatan

Active Comparator

Intervention: Travoprost (TRAVATAN) (Drug)

Outcomes

Primary Outcomes

Mean IOP

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Completed
Phase 2
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle Glaucoma
NCT00287521Alcon Research87
Completed
Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular Hypertension
NCT00314158Alcon Research523
Completed
Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular Hypertension
NCT00314171Alcon Research437
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular Hypertension
NCT00293787Alcon Research156
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular Hypertension
NCT00293800Alcon Research173